Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
L. Minarowski, A. Minarowska, D. Sands, A. Karwowska (Bialystok, Warsaw, Poland). Clinical status and activity of lysosomal carboxypeptidase A and cathepsin D in mixed saliva of cystic fibrosis patients. Eur Respir J 2008; 32: Suppl. 52, 1241

Member's Comments

No comment yet.

Related content which might interest you: The activity of selected proteolytic enzymes in saliva of cystic fibrosis patients Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 Late Breaking Abstract: The activity of selected salivary proteases and glycosidases in whole saliva of cystic fibrosis patients Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 Targeting of cathepsin S reduces cystic fibrosis-like lung disease Source: Eur Respir J, 53 (3) 1801523; 10.1183/13993003.01523-2018 Year: 2019 Lysosomal cysteine proteases in the lung: role in protein processing and immunoregulation Source: Eur Respir J 2004; 23: 620-628 Year: 2004 Decreased levels of secretory leucoprotease inhibitor in the pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009 SerpinB1 in cystic fibrosis airway fluids: quantity, molecular form and mechanism of elastase inhibition Source: Eur Respir J 2011; 37: 1083-1090 Year: 2011 A role for cathepsin S in the pathogenesis of cystic fibrosis lung disease? Source: Annual Congress 2011 - Cell biology of lung disease Year: 2011 Short-term variability of biomakers of proteinase activity in patients with emphysema associated with type Z alpha-1-antitrypsin deficiency Source: Eur Respir J 2004; 24: Suppl. 48, 459s Year: 2004 Inhibition of airway proteases in cystic fibrosis lung disease Source: Eur Respir J 2008; 32: 783-795 Year: 2008 Definition of trypsin-like enzymes activity as the marker of severity of idiopathic pulmonary fibrosis Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias Year: 2018 Neutrophil functional activity of patients with cystic fibrosis Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health Year: 2008 Neutrophil functional activity of patients with cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 385s Year: 2004 The role of serum cathepsin S levels in sarcoidosis Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 Vitamin D status correlates with lung function in children and adolescents with cystic fibrosis. Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis Year: 2020 Development of secretory leukocyte protease inhibitor (SLPI) variants resistant to degradation by neutrophil elastase Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases Year: 2014 Cathepsins in bleomycin-induced lung injury in rat Source: Eur Respir J 2003; 22: 427-435 Year: 2003 A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection Source: Lung Science Conference 2015 Year: 2015 Diagnostic value of vascular endothelial growth factor, glycosaminoglycan, cathepsin S, cathepsin H in the discrimination of transudate exudate and benign malignant patients with pleural effusion Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions Year: 2012 LSC Abstract – A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015 Localizing the proteolytic activity: lysosomal and extracellular Cystein cathepsins Source: ERS Research Seminar 2015 Year: 2015